Biomarker Discovery Services

About ImmunoMind

ImmunoMind is an AI-driven biotech startup building an open-source ecosystem for personalized immunotherapy and vaccine design. Its technology platform, rooted in the widely-used Immunarch bioinformatics tool, applies machine learning to single-cell and bulk multi-omics data to analyze immune cell populations, with a strong initial focus on improving CAR-T cell therapy development. The company targets biopharma partners, biotech startups, and research institutions, aiming to de-risk drug discovery, enhance clinical trial success, and fuel novel biomarker discovery. As a pre-revenue platform company, its growth is tied to strategic partnerships with major pharmaceutical and academic entities.

About BioChain

BioChain has established itself as a critical enabler in the precision medicine ecosystem by providing an end-to-end platform from biological samples to genomic data analysis. Founded in 1996 and headquartered in Newark, California, the company serves a global clientele of researchers and diagnostic developers with high-quality reagents, biospecimens, and sequencing services. Its business model is built on a diagnostics and services platform, generating revenue through the sale of products and contract research. While privately held, BioChain occupies a strategic niche by reducing friction in the translational research pipeline, though it faces competition from larger reagent suppliers and diagnostic service providers.

About Wasatch BioLabs

Wasatch BioLabs is a specialized service provider in the genetics and genomics sector, built around proprietary long-read sequencing platforms for integrated genomic and epigenomic data. Its core innovation is the Direct Whole Methylome Sequencing (dWMS) platform, which enables bisulfite-free, PCR-free methylation analysis alongside variant detection. Positioning itself as the first full-scale clinical lab dedicated to Oxford Nanopore sequencing, the company targets the high-growth areas of precision health, biomarker discovery, and scalable clinical assay deployment.

About IMGM Laboratories

IMGM Laboratories is a well-established, privately-held German CRO providing specialized genomic services to the life sciences industry. Its core expertise lies in molecular genetics, medical diagnostics, and high-throughput sequencing, with key service pillars in metagenomics, pharmacogenetics, biomarker discovery, and GLP-compliant biodistribution studies. The company operates on a fee-for-service business model, catering to academic, biotech, and pharma clients with a focus on flexibility, quality assurance, and comprehensive data analysis. With over two decades of experience, IMGM positions itself as a trusted outsourcing partner for complex genomic projects.

Therapeutic Areas

Other Multiple Drugs